Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TKPHF - Takeda gets positive CHMP opinion for subcutaneous vedolizumab


TKPHF - Takeda gets positive CHMP opinion for subcutaneous vedolizumab

  • Takeda Pharmaceutical (OTCPK:TKPHF) gets a positive CHMP opinion recommending approval of the subcutaneous form of vedolizumab biologic for maintenance therapy in adults with moderately to severely active ulcerative colitis or Crohn's disease.
  • More news on: Takeda Pharmaceutical Company Limited, Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: Takeda Pharmaceutical Co Ltd
Stock Symbol: TKPHF
Market: OTC
Website: takeda.com

Menu

TKPHF TKPHF Quote TKPHF Short TKPHF News TKPHF Articles TKPHF Message Board
Get TKPHF Alerts

News, Short Squeeze, Breakout and More Instantly...